May 5, 2023
SIGA Reports Financial Results for Three Months Ended March 31, 2023
– Corporate Update Conference Call Today at 4:30 PM ET -NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) — SIGA Technologies,…
Pharmaceuticals, Biotechnology and Life Sciences
– Corporate Update Conference Call Today at 4:30 PM ET -NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) — SIGA Technologies,…
Two phase 1 clinical trials recruiting patients at 14 sites across the US; nine sites for LYL797, a ROR-1-targeted chimeric…
Stockholders to Receive $1.85 Per Share in Cash Plus Contingent Value RightsCAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) — Jounce…
SUNNYVALE, Calif., May 03, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the…
IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet…
– Oral presentations demonstrate positive preclinical data highlighting CD388’s activity against influenza A and B –SAN DIEGO, May 03, 2023…
Immunocore to present at the Bank of America Securities 2023 Health Care Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE,…
COPENHAGEN, Denmark, May 03, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President &…
Company to Host Conference Call Today, May 3, at 4:30pm ETBOCA RATON, Fla., May 03, 2023 (GLOBE NEWSWIRE) — INmune…
SOUTH SAN FRANCISCO, Calif., May 03, 2023 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE) (DICE or the Company), a…